# Effect of Intranasal Mupirocin on Rate of Staphylococcus Aureus Surgical Site Infection Following Cesarean Sections

> **NCT01152593** · NA · UNKNOWN · sponsor: **Hillel Yaffe Medical Center** · enrollment: 400 (estimated)

## Conditions studied

- Surgical Wound Infection
- Cesarean Section
- Staphylococcus Aureus

## Interventions

- **DRUG:** Mupirocin

## Key facts

- **NCT ID:** NCT01152593
- **Lead sponsor:** Hillel Yaffe Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-07
- **Primary completion:** 2014-07
- **Final completion:** 2014-12
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2010-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01152593

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01152593, "Effect of Intranasal Mupirocin on Rate of Staphylococcus Aureus Surgical Site Infection Following Cesarean Sections". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01152593. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*